What happened Shares of Enphase Energy (NASDAQ: ENPH) have popped today, up by 17% as of 1 p.m. EDT, after S&P Dow Jones Indices announced that it would be adding the company to the S&P MidCap 400 index.

Core Laboratories (CLB) delivered earnings and revenue surprises of -8.82% and 0.51%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

The Board of Supervisory Directors of Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam Exchange: "CLB NA") has announced a cash dividend of $0.01 per share of common stock payable in the second quarter of 2020. This second quarter dividend amount, if maintained for the remaining quarters of the year, and when added to the Q1 2020 dividend of $0.25 per share, would mean a total payout for the year of $0.28 per share of common stock. The second quarter $0.01 per share cash dividend will be payable on Tuesday, 19 May 2020, to shareholders of record on Friday, 8 May 2020. Dutch withholding tax will be deducted from the dividend at a rate of 15%.

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") is announcing immediate actions in response to current market volatility, operational disruption related to COVID-19, and the oil and gas industry outlook. In addition, Core Lab is making further corporate and operating cost reductions and reducing its 2020 capital expenditure program to align with the Company's client activity. The Company also feels it is appropriate to withdraw its first quarter 2020 guidance, last provided on January 29, 2020.

To the annoyance of some shareholders, Core Laboratories (NYSE:CLB) shares are down a considerable 71% in the last...

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA"), (the "Company" or "Core Lab") announces that on March 20, 2020, it filed its definitive proxy on form DEF-14A with the U.S. Securities and Exchange Commission (the "SEC") setting the Company's 2020 annual shareholder meeting in Amsterdam, the Netherlands, for May 20, 2020 at 9:00 a.m. CEST.

After oil supply surged in March, investors took a more positive view in April. But this story is far from over, especially for this trio.

Q1 2020 Core Laboratories NV Earnings Call

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in first quarter 2020 revenue of $152,400,000. The financial results for the first quarter of 2020 include a non-cash charge of $122,000,000 for the impairment of goodwill and intangible assets in the Production Enhancement segment, a charge of $1,000,000 associated with reductions in the workforce and other items. Core's operating loss was $(109,000,000), with a loss per diluted share ("EPS") of $(2.44), all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $20,600,000, yielding operating margins of 13.5% and EPS, ex-items, of $0.31. A full reconciliation of non-GAAP financial measures is included in the attached financial tables. First quarter operating margins for the Company, across both the Reservoir Description and Production Enhancement segments, were negatively affected by operational workflow disruptions such as travel, product delivery and quarantine restrictions as a result of Coronavirus 2019 ("COVID-19").

In a bid to sustain a strong balance sheet and lower the debt load, Core Labs (CLB) trims its quarterly cash dividend to a penny per share from the prior dividend of 25 cents.

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Those holding Core Laboratories (NYSE:CLB) shares must be pleased that the share price has rebounded 45% in the last...

Let's see if Core Laboratories (CLB) stock is a good choice for value-oriented investors right now from multiple angles.

Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2020 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 23, 2020.

Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Though the magnitude of loss due to the virus outbreak in Abbott's (ABT) Core Laboratory business is still unclear, the company's point-of-care business is anticipated to generate profit.

BP plc (BP) missed earnings estimates, Kinder Morgan (KMI) reported in line, while Baker Hughes (BKR) came out with better-than-expected bottom-line number.

We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]

This energy services company reported terrible earnings a week ago, but in today's wild oil market, that's ancient history.

The Zacks Analyst Blog Highlights: Schlumberger, Halliburton, Core Laboratories, ProPetro and Oceaneering International